174 related articles for article (PubMed ID: 35519189)
1. Early detection of metabolic changes in drug-induced steatosis using metabolomics approaches.
Yong HY; Larrouy-Maumus G; Zloh M; Smyth R; Ataya R; Benton CM; Munday MR
RSC Adv; 2020 Nov; 10(67):41047-41057. PubMed ID: 35519189
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations.
García-Cañaveras JC; Donato MT; Castell JV; Lahoz A
J Proteome Res; 2011 Oct; 10(10):4825-34. PubMed ID: 21830829
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics profiling of steatosis progression in HepaRG
Cuykx M; Claes L; Rodrigues RM; Vanhaecke T; Covaci A
Toxicol Lett; 2018 Apr; 286():22-30. PubMed ID: 29355688
[TBL] [Abstract][Full Text] [Related]
4. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
[TBL] [Abstract][Full Text] [Related]
5. Glial cell line-derived neurotrophic factor-induced mice liver defatting: A novel strategy to enable transplantation of steatotic livers.
Taba Taba Vakili S; Kailar R; Rahman K; Nezami BG; Mwangi SM; Anania FA; Srinivasan S
Liver Transpl; 2016 Apr; 22(4):459-67. PubMed ID: 26714616
[TBL] [Abstract][Full Text] [Related]
6. ¹H and ³¹P NMR lipidome of ethanol-induced fatty liver.
Fernando H; Kondraganti S; Bhopale KK; Volk DE; Neerathilingam M; Kaphalia BS; Luxon BA; Boor PJ; Shakeel Ansari GA
Alcohol Clin Exp Res; 2010 Nov; 34(11):1937-47. PubMed ID: 20682011
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive quantification of triglyceride content in steatotic rat livers by (1)H-MRS: when water meets (too much) fat.
Heger M; Marsman HA; Bezemer R; Cloos MA; van Golen RF; van Gulik TM
Acad Radiol; 2011 Dec; 18(12):1582-92. PubMed ID: 22055799
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatic steatosis activity of Sicyos angulatus extract in high-fat diet-fed mice and chemical profiling study using UHPLC-qTOF-MS/MS spectrometry.
An JP; Choi JH; Huh J; Lee HJ; Han S; Noh JR; Kim YH; Lee CH; Oh WK
Phytomedicine; 2019 Oct; 63():152999. PubMed ID: 31280138
[TBL] [Abstract][Full Text] [Related]
9. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature.
Tambay V; Raymond VA; Goossens C; Rousseau L; Turcotte S; Bilodeau M
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370840
[TBL] [Abstract][Full Text] [Related]
11. Combination of LC/MS and GC/MS based metabolomics to study the hepatotoxic effect of realgar nanoparticles in rats.
Zhang MH; Chen JQ; Guo HM; Li RT; Gao YQ; Tian Y; Zhang ZJ; Huang Y
Chin J Nat Med; 2017 Sep; 15(9):684-694. PubMed ID: 28991530
[TBL] [Abstract][Full Text] [Related]
12. Quantifying hepatic steatosis - more than meets the eye.
Levene AP; Kudo H; Armstrong MJ; Thursz MR; Gedroyc WM; Anstee QM; Goldin RD
Histopathology; 2012 May; 60(6):971-81. PubMed ID: 22372668
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific metabolomics characterizes the hepatotoxicity of Dioscorea bulbifera rhizome in rats by integration of GC-MS and
Zhao DS; Wu ZT; Li ZQ; Wang LL; Jiang LL; Shi W; Li P; Li HJ
J Ethnopharmacol; 2018 Nov; 226():111-119. PubMed ID: 30114519
[TBL] [Abstract][Full Text] [Related]
14. Tetracycline-induced steatosis in primary canine hepatocyte cultures.
Amacher DE; Martin BA
Fundam Appl Toxicol; 1997 Dec; 40(2):256-63. PubMed ID: 9441722
[TBL] [Abstract][Full Text] [Related]
15. Identification of metabolites from liquid chromatography-coulometric array detection profiling: gas chromatography-mass spectrometry and refractionation provide essential information orthogonal to LC-MS/microNMR.
Gathungu RM; Bird SS; Sheldon DP; Kautz R; Vouros P; Matson WR; Kristal BS
Anal Biochem; 2014 Jun; 454():23-32. PubMed ID: 24657819
[TBL] [Abstract][Full Text] [Related]
16. Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via
Chen M; Lu S; Zheng H; Xu M; Song J; Yang W; Weng Q; Zheng L; Fan X; Cheng X; Gao H; Ji J
Biomed Res Int; 2019; 2019():9367082. PubMed ID: 30719453
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS.
Bao Y; Wang S; Yang X; Li T; Xia Y; Meng X
J Ethnopharmacol; 2017 Feb; 198():468-478. PubMed ID: 28108381
[TBL] [Abstract][Full Text] [Related]
18. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
19. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.
Lendvai G; Jármay K; Karácsony G; Halász T; Kovalszky I; Baghy K; Wittmann T; Schaff Z; Kiss A
World J Gastroenterol; 2014 Nov; 20(41):15343-50. PubMed ID: 25386083
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
